The Public Financing of Pharmaceuticals: An Economic Approach - Image 1

£65.49

Edward Elgar Publishing The Public Financing of Pharmaceuticals: An Economic Approach

Name: The Public Financing of Pharmaceuticals: An Economic Approach
Brand: Edward Elgar Publishing
Price: 67.57 GBP
Availability: InStock

Economics

Price History & Forecast

Last 84 days • 84 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 84 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £68 (53 days, 63.1%)

Price range: £65 - £68

Price levels: 3 different prices over 84 days

Description

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability. The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription? Jaume Puig-Junoy has performed an invaluable task in creating a cohesive, and analytically rigorous book of specially commissioned chapters on this pertinent topic. The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries and policymakers.

Product Specifications

Brand: Edward Elgar Publishing
Format: hardcover
ASIN: 1845420888
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 24 February 2005
Listed Since: 10 December 2006

Barcode

No barcode data available

Edward Elgar Publishing The Public Financing of Pharmaceuticals: An Economic Approach

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Global Issues in Pharmaceutical Marketing

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Equitable Access to High-Cost Pharmaceuticals

Global Pharmaceutical Policy

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Public Health, Personal Health and Pills: Drug Entanglements and Pharmaceuticalised Governance (Routledge Studies in the Sociology of Health and Illness)

Kommunikations-Strategien im Pharma-Markt: Verhaltenswissenschaftliche Ansätze zur Ärzte- und Patienten-Ansprache im Markt für verschreibungspflichtige Präparate: 35 (Konsum und Verhalten, 35)

Drug Control and International Law (Routledge Research in International Law)

Drug Information: A Guide for Pharmacists, Fourth Edition

A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines

Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Optimization of Pharmaceutical Processes: 189 (Springer Optimization and Its Applications, 189)

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Care in Digital Revolution: Blending Digital with Human Innovation

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

MTM Guide for Independent Consulting Pharmacists: Freedom. Unlimited income potential. Sense of Control.

Quality Control of Pharmaceuticals: Compendial Standards and Specifications

Converging Pharmacy Science and Engineering in Computational Drug Discovery (Advances in Healthcare Information Systems and Administration)